medigraphic.com
Colegio de Medicina Interna de México.

2011, Number 6

<< Back Next >>

Med Int Mex 2011; 27 (6)

Fever of unknown origin. The challenge of the Internal Medicine

Palafox CG, Martín CHJP

Language: Spanish
References: 39
Page: 573-585
PDF size: 286.68 Kb.


ABSTRACT

When a patient has met the criteria for the definition of Fever of Unknown Origin (FUO), this represents a challenge in the study of Medicine by requiring skill and experience of medical diagnostic methods used to it, considering again basic studies, and maybe even to the most current and modern. Many diseases have as the first presentation this sign, so it should be suspected on clinical tools and be studied intelligently and directed by laboratory and imaging methods for the timely diagnosis of the same, because some diseases require diligent and swift treatment.
The revised information on ODF, it provides new concepts and ways to address that have not been integrated, that is why we seek through the following paragraphs give a brief summary to take an approach to its study in a spirit of practical and easily understood without losing the center line of study.


REFERENCES

  1. Hot A, Jaisson I, Girard C, French M, et al. Yield of bone marrow examination in diagnosing the source of fever of unknown origin. Arch Intern Med 2009; 169(21):2018-2023.

  2. Lozano F, León E, Gómez-Mateos J, et al. Fiebre de origen desconocido. Actitudes diagnósticas En: Medicine 1998; 3558-3566.

  3. García-Ordóñez M, Colmenero MJ, Jiménez-Oñate F, Martos F, et al. Diagnostic Usefulness of Percutaneous Liver Biopsy in HIV-Infected patients with Fever of Unknown Origin. Journal of Infection 1999;38:94-98.

  4. Kasper D, Braunwald E, Fauci A, Hauser S, et al. Harrison´s. Principles of Internal Medicine. 16a ed. New York: McGraw- Hill, 2005;108-121.

  5. Cuello C, Támez L, Valdéz J. Leucocitos en sangre, eritrosedimentación y proteína C reactiva en pacientes de 0 a 90 días de edad con fiebre sin focalización. An Pediatr (Barc) 2008;68(2):103-109.

  6. Ruiz S, García A, Rodado S, De la Torre M, y col. Diagnóstico de las complicaciones infecciosas de la diálisis peritoneal continua ambulatoria mediante leucocitos marcados con 99mTc- HMPAO. Rev Esp Med Nucl 2004;23(6):403-413.

  7. Forsvoll J, Oymar K. C-reactive protein in the periodic fever, aphtous somatitis, pharyngitis and cervical adenitis (PFAPA) syndrome. Acta Paediatrica 2007;96:1670-1673.

  8. Williams J, Bellamy R. Fever of unknown origin. Clinical Medicine 2008;8:526-530.

  9. Castagnola E, Fontana V, Caviglia I, Caruso S, et al. A prospective study on the Epidemiology of Febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clinical Infectious Diseases 2007;45:1296-1304.

  10. Firmansyah I, Jong J, Nainggolan L. Liver tuberculosis as an etiology in fever of unknown origin. J Intern Med 2005;37:91-93.

  11. Holtz T, Moseley R, Scheiman J. Liver biopsy in fever of unknown origin. J Clin Gastroenterol 1993;17(1):29-32.

  12. Castagnola E, Fontana V, Caviglia I, Caruso S, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clinical Infectious Diseases 2007;45:1296-1304.

  13. Gungor F, Karayalcin B, Gultekin M, Paksoy N, et al. Comparison of Tc-99m HIG and Ga-67 citrate in the evaluation of bacterial abscess in a rat model. Annals of Nuclear Medicine 1996;10(1):79-83.

  14. Toft, H, Mellemkjaer L, Vinther M, Johnsen S, et al. Fever of unknown origin and cancer: a population-based study. Lancet Oncol 2005;6:851-855.

  15. Cunha B. Fever of unknown origin: clinical overview of classic and current concepts. Infect Dis Clin N Am 2007;21:867-915.

  16. Romo J, Muñoz J. Protocolo diagnóstico en fiebre de origen desconocido para países en vías de desarrollo. Anales de la Facultad de Medicina 2004;65(2): 127-132.

  17. Cummings S, Lally K, Pineiro-Carrero V, Beck D. Colonic leiomyoma. An unusual cause of gastrointestinal hemorrhage in childhood: Report of a case. Dis Colon Rectum 1990;33:511-514.

  18. Lee N. Case records of the Massachusetts General Hospital. N Engl J Med 2002;347(3):200-206.

  19. Mourad O, Palda V, Detsky A. A Comprehensive evidencebased approach to fever of unknown origin. Arch Inter Med 2003;163:545-551.

  20. Guyton A, Hall J. Tratado de Fisiología Médica. 9ª. México: McGraw-Hill Interamericana, 1998;993-1006.

  21. Kjaer A, Lebech A. Journal of Nuclear Medicine 2002;43:140-144.

  22. Ramiro HM, Lifshitz A, Halabe J, Frati MA. El Internista. Medicina Interna para Internistas. 3ª ed. México: Nieto editores, 2009;1217-1221, 1292-1306.

  23. Andreola B, Bressan S, Callegaro S, Liverani A, et al. Procalcitonin and C-Reactive protein as diagnostic markers of severe bacterial infection in febrile infants and children in the Emergency Department. Pediatr Infect Dis J 2007;26:672-677.

  24. Meller J, Sahlmann C, Gurocak O, Liersch T, Meller B. FDGPET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009;53:51-63.

  25. Alonso J. Estado actual de los estudios de medicina nuclear en procesos infecciosos e inflamatorios en España. Rev Esp Med Nuclear 2001;20(5):353-357.

  26. Ortega M, Fuster D, Setoain X, Fuertes S, y col. Absceso del psoas como causa de dolor lumbar detectado mediante gammagrafía con galio en un paciente con sospecha de espondiloliscitis. Rev Esp Med Nucl 2004;23(4):282-283.

  27. Balink H, Collins J, Bruyn G, Gemmel F. F-18 FDG PET/ CT in diagnosis of fever of unknown origin. Clinical Nuclear Medicine 2009;34:862-868.

  28. Bodey G. Fever and neutropenia: the early years. J Antimicrob Chem 2009;63 (Suppl 1):i3-i13.

  29. Babu C, McQuillan O, Kingsto, M. Management of pyrexia of unknown origin in HIV-positive patients. Int J STD & AIDS 2009;20:369-372.

  30. Bleeker C, Vos F de Kleijn, Mudde E, Dofferhoff A, Richter T, et al. A prospective multicenter study on fever of unknown origin. The Yield of a Structured Diagnostic Protocol. Medicine 2007;86:26-38.

  31. Enciclopedia Hispánica. Londres: Encyclopedia Britannica Publishers 1991;394-395.

  32. Lifshitz A. Fiebre y otras formas de elevación térmica. Revista de Investigación Clínica 2007;59(2):130-138.

  33. Arnaud H, Schmulewitz L, Viard J, Northolary O. Fever of Unknown Origin in HIV/AIDS Patients. Infect Dis Clin N Am 2007;21:1013-1032.

  34. Klastersky J. Why empirical therapy? J Antimicrobial Chemother 2009;63(Suppl): i14-i15.

  35. Pizzo P. Where do we go from here? J Antimicrobial Chemother 2009;63(Suppl 1): i16-i17.

  36. Williams K. Why monotherapy? J Antimicrob Chemother 2009;63(Suppl 1): i18-i20.

  37. Bustamante C. Síndrome de inmunodeficiencia adquirida. Actualización en Infectología 2003;1(6):39-46.

  38. Belloso W. Virus de la inmunodeficiencia humana y síndrome de la inmunodeficiencia adquirida (1a parte). Evid Actual Pract Ambul 2005;8:21-23.

  39. Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Digestive Diseases and Sciences 2003;48(4):677-682.




2020     |     www.medigraphic.com